Back
Apellis Pharmaceuticals, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
47
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$22.20
Seasonality Move:
12.69%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.17 | Buy |
| 20-day SMA: | 20.27 | Buy |
| 50-day SMA: | 22.91 | Sell |
| 200-day SMA: | 22.01 | Buy |
| 8-day EMA: | 21.16 | Buy |
| 20-day EMA: | 21.18 | Buy |
| 50-day EMA: | 22.28 | Sell |
| 200-day EMA: | 24.24 | Sell |
Apellis Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 54.46 | Buy |
| Chaikin Money Flow: | 1529040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.54 - 21.16) | Buy |
| Bollinger Bands (100): | (20.39 - 26.83) | Sell |
Apellis Pharmaceuticals, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals, Inc. Stock
Is Apellis Pharmaceuticals, Inc. Stock a Buy?
-
Apellis Pharmaceuticals, Inc. share price is 22.19 while APLS 8-day simple moving average is 21.17, which is a Buy signal.
-
The stock price of APLS is 22.19 while Apellis Pharmaceuticals, Inc. 20-day SMA is 20.27, which makes it a Buy.
-
Apellis Pharmaceuticals, Inc. 50-day simple moving average is 22.91 while APLS share price is 22.19, making it a Sell technically.
-
APLS stock price is 22.19 and Apellis Pharmaceuticals, Inc. 200-day simple moving average is 22.01, creating a Buy signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
47
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. a Buy or a Sell?
-
Apellis Pharmaceuticals, Inc. stock is rated a SellThe current Apellis Pharmaceuticals, Inc. [APLS] share price is $22.19. The Score for APLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals, Inc. Stock Info
Market Cap:
2.8B
Price in USD:
22.19
Share Volume:
2.6M
Apellis Pharmaceuticals, Inc. 52-Week Range
52-Week High:
35.72
52-Week Low:
16.10
Sell
47
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Apellis Pharmaceuticals, Inc. Share Price Forecast
-
What is the Apellis Pharmaceuticals, Inc. stock price today?The Apellis Pharmaceuticals, Inc. stock price is 22.19 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals, Inc. is overvalued.
Is Apellis Pharmaceuticals, Inc. Stock a Buy?
-
Apellis Pharmaceuticals, Inc. share price is 22.19 while APLS 8-day exponential moving average is 21.16, which is a Buy signal.
-
The stock price of APLS is 22.19 while Apellis Pharmaceuticals, Inc. 20-day EMA is 21.18, which makes it a Buy.
-
Apellis Pharmaceuticals, Inc. 50-day exponential moving average is 22.28 while APLS share price is 22.19, making it a Sell technically.
-
APLS stock price is 22.19 and Apellis Pharmaceuticals, Inc. 200-day simple moving average is 24.24, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals, Inc.
Is Apellis Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Technical Analysis of Apellis Pharmaceuticals, Inc.
Should I short Apellis Pharmaceuticals, Inc. stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Apellis Pharmaceuticals, Inc. is a Sell
-
Apellis Pharmaceuticals, Inc. Relative Strength Index (RSI) is 54.46, which suggest Apellis Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals, Inc. is (19.54 - 21.16), which suggest Apellis Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals, Inc. is (20.39 - 26.83), which suggest Apellis Pharmaceuticals, Inc. is a Sell
* Apellis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.